Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Athyrium Capital Management, LP

Investor type Private Equity Firm
Founders Jeffrey A Ferrell

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 39
Average round size
info
The average size of a deal this fund participated in
$132M
Portfolio companies 30
Rounds per year 2.79
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 23
Key employees 8
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Software
Summary

In 2008 was created Athyrium Capital Management, LP, which is appeared as VC. The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2014. Comparing to the other companies, this Athyrium Capital Management, LP performs on 10 percentage points more the average number of lead investments. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of more than 100 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Diagnostics, E-Commerce. Among the various public portfolio startups of the fund, we may underline Clover Health, VillageMD, TRIA Beauty Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Athyrium Capital Management, LP, startups are often financed by Oxford Finance LLC, Avista Capital Partners, WFD Ventures. The meaningful sponsors for the fund in investment in the same round are First Round Capital, Wildcat Venture Partners, Vivo Capital. In the next rounds fund is usually obtained by Greenoaks Capital, Wildcat Venture Partners, Sequoia Capital.

This organization was formed by Jeffrey A Ferrell. The overall number of key employees were 8.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Athyrium Capital Management, LP:
Typical Co-investors
Athyrium Capital Management, LP is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Athyrium Capital Management, LP:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
7cool China, Jiangsu, Wuxi Shi
Beijing Changping Technology Innodevelop Group Beijing, Beijing, China
Developing World Markets Connecticut, Stamford, United States
Henglu Assets China, Shanghai
NXT -
Research Corporation Technologies Arizona, Tucson, United States
Shonai Bank Japan, Tsuruoka, Yamagata Prefecture
Sirius Angel Fund Central, Central Region, Singapore
Y Experiment Greater Poland Voivodeship, Poland, Poznań
Yorkville Advisors Mountainside, New Jersey, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Basilea Pharmaceutica

Biotechnology
Commercial
Pharmaceutical
$81M07 Sep 2022 Basel, Basel-Stadt, Switzerland

uMotif

Data Visualization
Health Care
Information Services
Market Research
Medical
Software
$27M25 May 2022 London, England, United Kingdom

Revance Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$300M21 Mar 2022 California, United States

Puma Biotechnology

Biotechnology
Medical
Therapeutics
$10M10 Mar 2022 Los Angeles, California, United States

Osmotica Pharmaceutical

Biotechnology
Pharmaceutical
$100M07 Oct 2021 Marietta, Georgia, United States

Puma Biotechnology

Biotechnology
Medical
Therapeutics
$125M26 Jul 2021 Los Angeles, California, United States

BioCryst Pharmaceuticals

Biotechnology
Clinical Trials
Therapeutics
$325M07 Dec 2020 Birmingham, Alabama, United States

ArisGlobal

Biotechnology
Information Technology
Life Science
Natural Language Processing
Pharmaceutical
SaaS
Software
01 Jul 2019 Coral Gables, Florida, United States

Secura Bio

Biotechnology
Health Care
Pharmaceutical
$90M05 Mar 2019 Las Vegas, Nevada, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Athyrium Capital Management, LP?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: